应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02487 科笛-B
交易中 08-16 15:44:30
8.280
+0.250
+3.11%
最高
8.650
最低
8.010
成交量
157.66万
今开
8.160
昨收
8.030
日振幅
7.97%
总市值
25.18亿
流通市值
25.18亿
总股本
3.04亿
成交额
1,310万
换手率
0.52%
流通股本
3.04亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
科笛-B(02487)上涨5.23%,报8.45元/股
金融界 · 10:25
科笛-B(02487)上涨5.23%,报8.45元/股
科笛-B(02487)股价上升5.106%,现价港币$8.44
阿斯达克财经 · 10:14
科笛-B(02487)股价上升5.106%,现价港币$8.44
科笛-B08月15日获主力加仓100万元 环比增加300.00%
自选股智能写手 · 08-15 16:15
科笛-B08月15日获主力加仓100万元 环比增加300.00%
科笛-B早盘涨逾3% CU-30101药品上市许可申请获受理
新浪港股 · 08-13
科笛-B早盘涨逾3% CU-30101药品上市许可申请获受理
港股异动 | 科笛-B(02487)早盘涨超4% CU-30101药品上市许可申请获受理 进度超市场预期
智通财经 · 08-13
港股异动 | 科笛-B(02487)早盘涨超4% CU-30101药品上市许可申请获受理 进度超市场预期
中金:维持科笛-B(02487)“跑赢行业”评级 目标价降至11港元
智通财经 · 08-12
中金:维持科笛-B(02487)“跑赢行业”评级 目标价降至11港元
科笛-B08月05日遭主力抛售45万元 环比增加1025.00%
自选股智能写手 · 08-05
科笛-B08月05日遭主力抛售45万元 环比增加1025.00%
方正证券:利丁双卡因麻膏上市申请获受理 维持科笛-B(02487)“推荐”评级
智通财经网 · 08-02
方正证券:利丁双卡因麻膏上市申请获受理 维持科笛-B(02487)“推荐”评级
【方正证券:利丁双卡因麻膏上市申请获受理 维持科笛-B(02487.HK)“推荐”评级】智通财经APP获悉,方正证券发布研报称,科笛-B(02487.
智通财经 · 08-02
【方正证券:利丁双卡因麻膏上市申请获受理 维持科笛-B(02487.HK)“推荐”评级】智通财经APP获悉,方正证券发布研报称,科笛-B(02487.
暴涨30%到暴跌30%,科笛-B(02487)在上演“利好出货”戏码?
智通财经 · 08-01
暴涨30%到暴跌30%,科笛-B(02487)在上演“利好出货”戏码?
科笛-B(02487)股价大幅下跌28.738%,现价港币$7.34
阿斯达克财经 · 08-01
科笛-B(02487)股价大幅下跌28.738%,现价港币$7.34
科笛-B(02487)下跌20.58%,报8.18元/股
金融界 · 08-01
科笛-B(02487)下跌20.58%,报8.18元/股
【港股异动 | 科笛-B(02487.HK)午后涨超30% CU-30101上市申请获受理 CU-10201临床试验结果近日发表】智通财经APP获悉,科笛-B(02487.
智通财经 · 07-31
【港股异动 | 科笛-B(02487.HK)午后涨超30% CU-30101上市申请获受理 CU-10201临床试验结果近日发表】智通财经APP获悉,科笛-B(02487.
港股异动 | 科笛-B(02487)午后涨超30% CU-30101上市申请获受理 CU-10201临床试验结果近日发表
智通财经网 · 07-31
港股异动 | 科笛-B(02487)午后涨超30% CU-30101上市申请获受理 CU-10201临床试验结果近日发表
港股异动丨科笛涨近13%,CU-30101药品上市许可申请获受理科笛(2487.HK)盘中最高涨近13%至8.81港元,股价创逾2个月新高
格隆汇 · 07-31
港股异动丨科笛涨近13%,CU-30101药品上市许可申请获受理科笛(2487.HK)盘中最高涨近13%至8.81港元,股价创逾2个月新高
港股生物科技股集体走高,君圣泰医药-B涨超20%
老虎资讯综合 · 07-31
港股生物科技股集体走高,君圣泰医药-B涨超20%
科笛-B早盘涨超10% CU-30101药品上市许可申请获得受理
新浪港股 · 07-31
科笛-B早盘涨超10% CU-30101药品上市许可申请获得受理
科笛-B(02487)股价显著上升11.795%,现价港币$8.72
阿斯达克财经 · 07-31
科笛-B(02487)股价显著上升11.795%,现价港币$8.72
【港股异动 | 科笛-B(02487.HK)涨近9% CU-30101药品上市许可申请获得国家药品监督管理局受理】智通财经APP获悉,科笛-B(02487.
智通财经 · 07-31
【港股异动 | 科笛-B(02487.HK)涨近9% CU-30101药品上市许可申请获得国家药品监督管理局受理】智通财经APP获悉,科笛-B(02487.
科笛-B(02487)上涨10.26%,报8.6元/股
金融界 · 07-31
科笛-B(02487)上涨10.26%,报8.6元/股
加载更多
公司概况
公司名称:
科笛-B
所属市场:
SEHK
上市日期:
--
主营业务:
科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案,以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。
发行价格:
--
{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"科笛-B","latestPrice":8.28,"timestamp":1723794197387,"preClose":8.03,"halted":0,"volume":1576600,"delay":0,"floatShares":304152825,"shares":304152825,"eps":-10.422649,"marketStatus":"交易中","marketStatusCode":2,"change":0.25,"latestTime":"08-16 15:44:30","open":8.16,"high":8.65,"low":8.01,"amount":13101634,"amplitude":0.079701,"askPrice":8.32,"askSize":8800,"bidPrice":8.28,"bidSize":7400,"shortable":3,"etf":0,"ttmEps":-10.422649308236103,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1723795800000},"adr":0,"listingDate":1686499200000,"adjPreClose":8.03,"openAndCloseTimeList":[[1723771800000,1723780800000],[1723784400000,1723795200000]],"volumeRatio":2.225745,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02487","defaultTab":"news","newsList":[{"id":"2459237813","title":"科笛-B(02487)上涨5.23%,报8.45元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459237813","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459237813?lang=zh_cn&edition=full","pubTime":"2024-08-16 10:25","pubTimestamp":1723775131,"startTime":"0","endTime":"0","summary":"8月16日,科笛-B(02487)盘中上涨5.23%,截至10:25,报8.45元/股,成交261.91万元。科笛集团是一家以研发为主导的生物制药公司,主要专注于皮肤病治疗及护理市场,提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。公司利用专有的CATAME技术平台,形成了覆盖整个广泛皮肤病治疗及护理行业价值链的竞争优势,并由经验丰富的管理团队负责运营。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/16102542416657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2459232206","title":"科笛-B(02487)股价上升5.106%,现价港币$8.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2459232206","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459232206?lang=zh_cn&edition=full","pubTime":"2024-08-16 10:14","pubTimestamp":1723774440,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午10:14比前收市价上升5.106%,现股价为港币$8.44。至目前为止,今日最高价为$8.44,而最低价为$8.01。总成交量为26.04万股,总成交金额为港币$213.818万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2408162078/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2459141834","title":"科笛-B08月15日获主力加仓100万元 环比增加300.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459141834","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459141834?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:15","pubTimestamp":1723709716,"startTime":"0","endTime":"0","summary":"08月15日, 科笛-B股价涨0.88%,报收8.03元,成交金额633万元,换手率0.26%,振幅2.26%,量比1.17。科笛-B今日主力资金净流入100万元,上一交易日主力净流入25万元,今日环比增加300.00%。该股近5个交易日上涨7.64%,主力资金累计净流入49万元;近20日主力资金累计净流入1022万元,其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151615409f2d1058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408151615409f2d1058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2459990739","title":"科笛-B早盘涨逾3% CU-30101药品上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2459990739","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459990739?lang=zh_cn&edition=full","pubTime":"2024-08-13 10:45","pubTimestamp":1723517153,"startTime":"0","endTime":"0","summary":"科笛-B(02487)早盘上涨2.70%,现报7.98港元,成交额326.64万港元。\n 科笛近期发布公告,CU-30101(局部外用利多卡因丁卡因乳膏剂)药品上市许可申请已获得国家药监局受理,预计进度为全市场同类产品中最快;此外公司于7月12日发布回购计划,截至7月30日已累计购回股份58.58万股,占已发行总股本约0.19%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-13/doc-inciniqk3739621.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-08-13/doc-inciniqk3739621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2459420992","title":"港股异动 | 科笛-B(02487)早盘涨超4% CU-30101药品上市许可申请获受理 进度超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420992","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420992?lang=zh_cn&edition=full","pubTime":"2024-08-13 10:16","pubTimestamp":1723515393,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,科笛-B早盘涨超4%,截至发稿,涨3.6%,报8.05港元,成交额292.47万港元。消息面上,科笛近期发布公告,CU-30101药品上市许可申请已获得国家药监局受理,预计进度为全市场同类产品中最快;此外公司于7月12日发布回购计划,截至7月30日已累计购回股份58.58万股,占已发行总股本约0.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1163303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2458764528","title":"中金:维持科笛-B(02487)“跑赢行业”评级 目标价降至11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458764528","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458764528?lang=zh_cn&edition=full","pubTime":"2024-08-12 09:48","pubTimestamp":1723427317,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研究报告称,维持科笛-B“跑赢行业”评级,2024-25年收入及盈利预测不变。考虑到市场风险偏好变化及板块估值中枢下行,根据DCF模型,下调目标价13%至11港元。公司近期发布公告,CU-30101药品上市许可申请获得国家药监局受理。截至7月30日累计购回股份58.58万股,占已发行总股本约0.19%,彰显管理层对公司未来发展的信心。中金主要观点如下:1、表麻管线上市申请获受理,回购彰显管理层信心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1162733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02487"],"gpt_icon":0},{"id":"2457748883","title":"科笛-B08月05日遭主力抛售45万元 环比增加1025.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457748883","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457748883?lang=zh_cn&edition=full","pubTime":"2024-08-05 16:16","pubTimestamp":1722845781,"startTime":"0","endTime":"0","summary":"08月05日, 科笛-B股价跌0.28%,报收7.05元,成交金额832万元,换手率0.39%,振幅2.55%,量比0.29。科笛-B今日主力资金净流出45万元,连续3日净流出,上一交易日主力净流出4万元,今日环比增加1025.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为100.00%,平均跌幅为1.33%。该股近5个交易日下跌5.73%,主力资金累计净流入230万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入1402万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408051617109f0fa400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408051617109f0fa400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2456474463","title":"方正证券:利丁双卡因麻膏上市申请获受理 维持科笛-B(02487)“推荐”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2456474463","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456474463?lang=zh_cn&edition=full","pubTime":"2024-08-02 17:23","pubTimestamp":1722590633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,方正证券发布研报称,科笛-B的麻膏产品上市申请获受理,进度超市场预期。预计2024-2026年收入约2.83/5.9/10.02亿元,维持“推荐”评级。麻膏产品上市申请获受理,进度超市场预期公司发布公告,集团的CU-30101药品上市许可申请已获得国家药监局受理,预计进度为全市场同类产品中最快,当前麻膏产品合规占比低,预计获批后有望占领外用麻膏合规市场新蓝海。临床管线进展迅速,2024H2-2025有望上市3款重磅产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1159340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["601901","02487"],"gpt_icon":0},{"id":"2456474417","title":"【方正证券:利丁双卡因麻膏上市申请获受理 维持科笛-B(02487.HK)“推荐”评级】智通财经APP获悉,方正证券发布研报称,科笛-B(02487.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456474417","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456474417?lang=zh_cn&edition=full","pubTime":"2024-08-02 17:23","pubTimestamp":1722590633,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02487","601901","BK0183","BK0188","BK0276","BK1161","BK0122","BK0028","BK0012"],"gpt_icon":0},{"id":"2456917031","title":"暴涨30%到暴跌30%,科笛-B(02487)在上演“利好出货”戏码?","url":"https://stock-news.laohu8.com/highlight/detail?id=2456917031","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456917031?lang=zh_cn&edition=full","pubTime":"2024-08-01 17:03","pubTimestamp":1722503007,"startTime":"0","endTime":"0","summary":"7月31日,科笛-B股价开盘即开启“狂飙”姿态,从拉升态势从早盘持续到下午收盘,盘中涨幅一度突破33%,最终收涨32.05%,成交额3826.08万港元。消息面上,科笛当日发布公告,其CU-30101药品上市许可申请获得中国国家药品监督管理局受理。2020年至2022年上半年,科笛集团分别实现营收为0、203.8万元、65.8万元;同期净亏损分别为1.999亿、3.195亿和2.52亿元,累计亏损约为7.7亿元。直到2023年实现完整商业化年度后,科笛亏损的现象仍未好转,其2023年实现净亏损19.64亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1158749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"2456122343","title":"科笛-B(02487)股价大幅下跌28.738%,现价港币$7.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2456122343","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456122343?lang=zh_cn&edition=full","pubTime":"2024-08-01 13:57","pubTimestamp":1722491820,"startTime":"0","endTime":"0","summary":"[下跌股]科笛-B(02487) 股价在下午01:57比前收市价大幅下跌28.738%,现股价为港币$7.34。至目前为止,今日最高价为$10.0,而最低价为$7.34。总成交量为482.72万股,总成交金额为港币$3.802千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2408011073/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2456107231","title":"科笛-B(02487)下跌20.58%,报8.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2456107231","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456107231?lang=zh_cn&edition=full","pubTime":"2024-08-01 09:42","pubTimestamp":1722476556,"startTime":"0","endTime":"0","summary":"8月1日,科笛-B(02487)盘中下跌20.58%,截至09:42,报8.18元/股,成交687.61万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/08/01094241950926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2455971934","title":"【港股异动 | 科笛-B(02487.HK)午后涨超30% CU-30101上市申请获受理 CU-10201临床试验结果近日发表】智通财经APP获悉,科笛-B(02487.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455971934","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455971934?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:11","pubTimestamp":1722409892,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","03347","BK1141","BK1161","BK1583","02487"],"gpt_icon":0},{"id":"2455607971","title":"港股异动 | 科笛-B(02487)午后涨超30% CU-30101上市申请获受理 CU-10201临床试验结果近日发表","url":"https://stock-news.laohu8.com/highlight/detail?id=2455607971","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455607971?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:11","pubTimestamp":1722409892,"startTime":"0","endTime":"0","summary":"科笛-B(02487)午后涨超30%,截至发稿,涨30.26%,报10.16港元,成交额5270.85万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20240731/20240731151225_54433.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240731/20240731151225_54433.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03347","BK1576","02487","BK1161","BK1583","BK1141"],"gpt_icon":0},{"id":"2455594998","title":"港股异动丨科笛涨近13%,CU-30101药品上市许可申请获受理科笛(2487.HK)盘中最高涨近13%至8.81港元,股价创逾2个月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2455594998","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455594998?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:19","pubTimestamp":1722392340,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1161","02487"],"gpt_icon":0},{"id":"1149505522","title":"港股生物科技股集体走高,君圣泰医药-B涨超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149505522","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149505522?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:18","pubTimestamp":1722392323,"startTime":"0","endTime":"0","summary":"港股异动|生物科技股集体走高,$君圣泰医药-B(02511)$涨超20%,$科笛-B(02487)$涨超10%,$来凯医药-B(02105)$涨近7%,$盛禾生物-B(02898)$涨近5%","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HSCEI","02487","02105","02898","02511","07226","YANG","HSTECH"],"gpt_icon":0},{"id":"2455694636","title":"科笛-B早盘涨超10% CU-30101药品上市许可申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2455694636","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455694636?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:00","pubTimestamp":1722391249,"startTime":"0","endTime":"0","summary":"科笛-B(02487)早盘上涨10.26%,现报8.60港元,成交额520.145万港元。\n 科笛-B发布公告,集团的CU-30101药品上市许可申请获得中国国家药品监督管理局(国家药监局)受理。\n 据介绍,CU-30101是一种用于皮肤表皮手术的局部利多卡因丁卡因复合表皮麻醉乳膏剂。由于其成分的独特药代动力学特性,CU-30101的利多卡因和丁卡因组合配方可产生快速且持久的麻醉效果。利多卡因较丁卡因弥散更快且弥散范围更广,而丁卡因是一种长效氨基酸酯类局麻药,较利多卡因更亲脂,可在表皮角质层中浓缩。麻醉成分的全身吸收亦受到表皮乳膏配方的限制。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-31/doc-incfysvm9291219.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-31/doc-incfysvm9291219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2455546949","title":"科笛-B(02487)股价显著上升11.795%,现价港币$8.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2455546949","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455546949?lang=zh_cn&edition=full","pubTime":"2024-07-31 10:00","pubTimestamp":1722391200,"startTime":"0","endTime":"0","summary":"[上升股]科笛-B(02487) 股价在上午10:00比前收市价显著上升11.795%,现股价为港币$8.72。至目前为止,今日最高价为$8.72,而最低价为$7.98。总成交量为68.6万股,总成交金额为港币$584.965万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240731811/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2455943927","title":"【港股异动 | 科笛-B(02487.HK)涨近9% CU-30101药品上市许可申请获得国家药品监督管理局受理】智通财经APP获悉,科笛-B(02487.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455943927","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455943927?lang=zh_cn&edition=full","pubTime":"2024-07-31 09:42","pubTimestamp":1722390130,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02487","BK1161"],"gpt_icon":0},{"id":"2455943011","title":"科笛-B(02487)上涨10.26%,报8.6元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455943011","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455943011?lang=zh_cn&edition=full","pubTime":"2024-07-31 09:41","pubTimestamp":1722390101,"startTime":"0","endTime":"0","summary":"7月31日,科笛-B(02487)盘中上涨10.26%,截至09:41,报8.6元/股,成交182.66万元。科笛集团是一家专注于皮肤学的生物制药公司,主要业务是研发创新和全面的皮肤病治疗及护理解决方案。公司的目标是成为国际领先的研发型皮肤学平台,为消费者和患者提供创新、安全、有效的皮肤及脱发疾病等全方位的专业解决方案。截至2023年年报,科笛-B营业总收入1.38亿元、净利润-19.64亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/31094141919736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02487","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":0.0764},{"period":"1month","weight":0.1326},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.2003},{"period":"1year","weight":-0.6176},{"period":"ytd","weight":-0.2687}],"compareEarnings":[{"period":"1week","weight":0.0129},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.125},{"period":"6month","weight":0.0471},{"period":"1year","weight":-0.0666},{"period":"ytd","weight":0.0036}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"科笛集团是一家主要从事皮肤学生物药物研发和制造的中国公司。该公司致力于开发全面的解决方案,以满足患者及消费者在广泛皮肤病治疗及护理市场中多样化需求。该公司主要从事其核心产品CU-20401的临床试验。该产品主要用于治疗颏下脂肪堆积。该公司在中国国内市场和海外市场开展其业务。","exchange":"SEHK","name":"科笛-B","nameEN":"CUTIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科笛-B,02487,科笛-B股票,科笛-B股票老虎,科笛-B股票老虎国际,科笛-B行情,科笛-B股票行情,科笛-B股价,科笛-B股市,科笛-B股票价格,科笛-B股票交易,科笛-B股票购买,科笛-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科笛-B(02487)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科笛-B(02487)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}